Zeus Drugs Limited - Company Profile

It is a pharma public limited company based in New Delhi, Delhi, India, established in 2006.
2006 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Zeus Drugs Limited

Zeus Drugs Limited, a active public limited company, was established on 31 August 2006 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U85121DL2006PLC152815. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.

It upholds a compliant status. Employing 4 professional, Its leadership includes Rajiv Kumar Sharma (Director), Ritu Sharma (Director), Manni Kaushik (Additional Director). Past directors included Rajendra Prasad Sharma, Ritu Sharma, Dharam Pal Singh. It holds ₹8.96 M open charges and ₹6.20 M settled loans. Its latest AGM occurred on 20 September 2025, with the balance sheet filed on 31 March 2025. It is based at E 1576F/ F, Tigri Colony, New Delhi, Delhi, 110062.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85121DL2006PLC152815

  • Registration Number

    152815

  • Incorporation Date

    31 August 2006

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹1.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 1.50 M
  • Company Age 19 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 8.96 M
  • Satisfied Charges ₹ 6.20 M
  • Revenue Growth **** 0.60%
  • Profit Growth **** 1.36%
  • Ebitda **** 59.14%
  • Net Worth 4.24%
  • Total Assets -2.30%
Company report

Zeus Drugs Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Zeus Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Zeus Drugs Limited?
Current Directors
Name Designation Appointment Date Status
Rajiv Kumar Sharma Director 04 Sep 2006 Current
Ritu Sharma Director 21 Feb 2024 Current
Manni Kaushik Additional Director 24 Jul 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 12 Jun 2025 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Director 31 Jan 2024 Past
Pramod Abcsdd Director 29 Mar 2011 Past
Pramod Abcsdd Director 21 Aug 2014 Past
Pramod Abcsdd Director 25 Aug 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Zeus Drugs.

Zeus Drugs Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 0.6% increase. The company also saw a slight improvement in profitability, with a 1.36% increase in profit. The company's net worth moved up by a moderate rise of 4.24%.

Zeus Drugs revenue growth over time
Zeus Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 0.60%
*******
*******
*******
*******
Revenue from Operations
*******
 0.60%
*******
*******
*******
*******
Total Assets
*******
 -2.30%
*******
*******
*******
*******
Profit or Loss
*******
 1.36%
*******
*******
*******
*******
Net Worth
*******
 4.24%
*******
*******
*******
*******
EBITDA
*******
 59.14%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Zeus Drugs?

In 2023, Zeus Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹8,957,000.00

Satisfied Charges

₹6,200,000.00

Charges Breakdown by Lending Institutions
  • Others : 0.90 Cr
Latest Charge Details
Date Lender Amount Status
04 Sep 2025 Others ₹4.83 M Open
31 Aug 2024 Others ₹4.13 M Open
07 Apr 2014 Others ₹4.70 M Satisfied
18 Sep 2008 Punjab National Bank ₹1.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Zeus Drugs?

Zeus Drugs has a workforce of 4 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Zeus Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zeus Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Zeus Drugs
Recent Activity within the Organization
  • Charges

    A charge with Others of Rs. 4.83 M registered on 04 Sep 2025 with Charge ID 101156054 was modified on 12 Dec 2025. was recorded as a recent event.

  • Annual General Meeting

    Zeus Drugs Limited last Annual general meeting of members was held on 20 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 4.83 M with Charge ID 101156054 was registered on 04 Sep 2025. was completed.

  • Director Appointment

    Progress on Manni Kaushik was appointed as a Additional Director was appointed as a Additional Director on 24 Jul 2025 & has been associated with this company since 6 months 30 days . was documented.

  • Balance Sheet

    Progress on Zeus Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Charges

    The activity A charge registered on 07 Apr 2014 via Charge ID 10489972 with Others was fully satisfied on 01 Mar 2025. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Zeus Drugs Limited?

The CIN of Zeus Drugs Limited is U85121DL2006PLC152815.

Where is Zeus Drugs Limited headquartered?

Zeus Drugs Limited is headquartered at E 1576F/ F, Tigri Colony, New Delhi, Delhi, 110062.

When was Zeus Drugs Limited incorporated?

Zeus Drugs Limited was incorporated on 31 August 2006.

Who are the current directors of Zeus Drugs Limited?

The current directors of Zeus Drugs Limited are

What is the primary industry of Zeus Drugs Limited?

The primary industry of Zeus Drugs Limited is Trade.

Is Zeus Drugs Limited a listed company?

Zeus Drugs Limited is unlisted.

What is the capital structure of Zeus Drugs Limited?

The authorized capital of Zeus Drugs Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.

What is the compliance status of Zeus Drugs Limited?

The compliance status of Zeus Drugs Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available